A mathematical model of the impact of novel treatments on the A β burden in the Alzheimer’s brain, CSF and plasma
Identifieur interne : 003415 ( Main/Exploration ); précédent : 003414; suivant : 003416A mathematical model of the impact of novel treatments on the A β burden in the Alzheimer’s brain, CSF and plasma
Auteurs : David L. Craft [États-Unis] ; Lawrence M. Wein [États-Unis] ; Dennis J. Selkoe [États-Unis]Source :
- Bulletin of Mathematical Biology [ 0092-8240 ] ; 2002-09-01.
Abstract
Abstract: With the advent of novel therapies for Alzheimer’s disease, there is a pressing need for biomarkers that are easy to monitor, such as the amyloid-beta (Aβ) levels in the cerebrospinal fluid (CSF) and plasma. To gain a better understanding of the explanatory power of these biomarkers, we formulate and analyze a compartmental mathematical model for the Aβ accumulation in the brain, CSF and plasma, throughout the course of Alzheimer’s treatment. Our analysis reveals that the total Aβ burden in the brain is dictated by a unitless quantity called the polymerization ratio, which is the product of the production and elongation rates divided by the product of the fragmentation and loss rates. In this ratio, the production rate and loss rate include a source and sink term, respectively, related to the intercompartmental transport. Our results suggest that production inhibitors are likely to reduce the Aβ levels in all three compartments. In contrast, agents that ingest monomers off of polymers, or that increase fragmentation or block elongation, may also reduce Aβ burden in the brain, but may produce little change in—or even transiently increase—CSF and plasma Aβ levels. Hence, great care must be taken when interpreting these biomarkers.
Url:
DOI: 10.1006/bulm.2002.0304
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000112
- to stream Istex, to step Curation: 000112
- to stream Istex, to step Checkpoint: 000D74
- to stream Main, to step Merge: 003451
- to stream Main, to step Curation: 003415
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">A mathematical model of the impact of novel treatments on the A β burden in the Alzheimer’s brain, CSF and plasma</title><author><name sortKey="Craft, David L" sort="Craft, David L" uniqKey="Craft D" first="David L." last="Craft">David L. Craft</name></author><author><name sortKey="Wein, Lawrence M" sort="Wein, Lawrence M" uniqKey="Wein L" first="Lawrence M." last="Wein">Lawrence M. Wein</name></author><author><name sortKey="Selkoe, Dennis J" sort="Selkoe, Dennis J" uniqKey="Selkoe D" first="Dennis J." last="Selkoe">Dennis J. Selkoe</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:1CCEE1A30E2671DD1A8851EB28BE57C7A2FED119</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1006/bulm.2002.0304</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-82X6CMNC-7/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000112</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000112</idno><idno type="wicri:Area/Istex/Curation">000112</idno><idno type="wicri:Area/Istex/Checkpoint">000D74</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D74</idno><idno type="wicri:doubleKey">0092-8240:2002:Craft D:a:mathematical:model</idno><idno type="wicri:Area/Main/Merge">003451</idno><idno type="wicri:Area/Main/Curation">003415</idno><idno type="wicri:Area/Main/Exploration">003415</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">A mathematical model of the impact of novel treatments on the A β burden in the Alzheimer’s brain, CSF and plasma</title><author><name sortKey="Craft, David L" sort="Craft, David L" uniqKey="Craft D" first="David L." last="Craft">David L. Craft</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Operations Research Center, MIT, 02139, Cambridge, MA</wicri:regionArea><wicri:noRegion>MA</wicri:noRegion></affiliation></author><author><name sortKey="Wein, Lawrence M" sort="Wein, Lawrence M" uniqKey="Wein L" first="Lawrence M." last="Wein">Lawrence M. Wein</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Sloan School of Management, MIT, 02139, Cambridge, MA</wicri:regionArea><wicri:noRegion>MA</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Selkoe, Dennis J" sort="Selkoe, Dennis J" uniqKey="Selkoe D" first="Dennis J." last="Selkoe">Dennis J. Selkoe</name><affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Center for Neurologic Diseases, Harvard Medical School, Brigham and Women’s Hospital, 02115, Boston, MA</wicri:regionArea><wicri:noRegion>MA</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Bulletin of Mathematical Biology</title><title level="j" type="abbrev">Bull. Math. Biol.</title><idno type="ISSN">0092-8240</idno><idno type="eISSN">1522-9602</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-09-01">2002-09-01</date><biblScope unit="volume">64</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="1011">1011</biblScope><biblScope unit="page" to="1031">1031</biblScope></imprint><idno type="ISSN">0092-8240</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0092-8240</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: With the advent of novel therapies for Alzheimer’s disease, there is a pressing need for biomarkers that are easy to monitor, such as the amyloid-beta (Aβ) levels in the cerebrospinal fluid (CSF) and plasma. To gain a better understanding of the explanatory power of these biomarkers, we formulate and analyze a compartmental mathematical model for the Aβ accumulation in the brain, CSF and plasma, throughout the course of Alzheimer’s treatment. Our analysis reveals that the total Aβ burden in the brain is dictated by a unitless quantity called the polymerization ratio, which is the product of the production and elongation rates divided by the product of the fragmentation and loss rates. In this ratio, the production rate and loss rate include a source and sink term, respectively, related to the intercompartmental transport. Our results suggest that production inhibitors are likely to reduce the Aβ levels in all three compartments. In contrast, agents that ingest monomers off of polymers, or that increase fragmentation or block elongation, may also reduce Aβ burden in the brain, but may produce little change in—or even transiently increase—CSF and plasma Aβ levels. Hence, great care must be taken when interpreting these biomarkers.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country></list><tree><country name="États-Unis"><noRegion><name sortKey="Craft, David L" sort="Craft, David L" uniqKey="Craft D" first="David L." last="Craft">David L. Craft</name></noRegion><name sortKey="Selkoe, Dennis J" sort="Selkoe, Dennis J" uniqKey="Selkoe D" first="Dennis J." last="Selkoe">Dennis J. Selkoe</name><name sortKey="Wein, Lawrence M" sort="Wein, Lawrence M" uniqKey="Wein L" first="Lawrence M." last="Wein">Lawrence M. Wein</name><name sortKey="Wein, Lawrence M" sort="Wein, Lawrence M" uniqKey="Wein L" first="Lawrence M." last="Wein">Lawrence M. Wein</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003415 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003415 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:1CCEE1A30E2671DD1A8851EB28BE57C7A2FED119
|texte= A mathematical model of the impact of novel treatments on the A β burden in the Alzheimer’s brain, CSF and plasma
}}
| This area was generated with Dilib version V0.6.33. |  |